Deep-dive & application

Data Sovereignty in Regulatory Submissions: Why In-Browser Modeling Keeps Your Formula Private

Answers: “protect formula data regulatory submission privacy CRO”

Your formula is your most valuable IP. Traditional evidence generation often means handing raw data to a CRO or uploading it to a vendor cloud — every handoff is exposure. For a competitive category, that risk is strategic, not just technical.

Why in-browser modeling changes the risk profile

  • Inputs (HPHC results, formulation parameters) are processed entirely in your browser — submission data never leaves your device.
  • No CRO handoff, no third-party cloud storage of your raw inputs.
  • You still export a validated, §1114.7-formatted report (print-to-PDF / HTML, with scenario JSON) and full citations.

Pros vs. cons. Pro: minimizes IP exposure while still producing reviewer-ready evidence; useful when screening many candidate formulas you don't want leaving the building. Con: in-browser processing means you are responsible for your own device security and record-keeping — no vendor archive to fall back on.

Who should NOT prioritize this: applicants already committed to a full-service CRO relationship who accept that data-sharing model.

FAQ

Does my formula data leave my device?

No — modeling runs in-browser; data stays local.

Do I still get an exportable report?

Yes — a §1114.7-formatted print-to-PDF / HTML report with citations.

References: Product methodology; general data-governance best practice for regulatory submissions.

See your formula’s evidence today

Run ELCR, in-silico PK and PHIA in your browser — a §1114.7-ready report in hours.

Start free — no signup
← All articles

Disclaimer: PMTA Hub tools generate model-based supporting evidence for regulatory decision-making. They do not constitute, and do not guarantee, FDA or NMPA authorization. Modeled evidence is typically combined with a confirmatory study in a weight-of-evidence submission.